Table 1.
Demographic and clinical characteristics.
| 719Arg carriers | 719Arg noncarriers | P value | |
|---|---|---|---|
| N | 106 | 69 | — |
| Males/females (n) | 54/52 | 39/30 | 0.47 |
| ApoE ε4 carrier/noncarrier (n) | 59/47 | 40/29 | 0.76 |
| Statin use/no statin use (n) | 59/47 | 46/23 | 0.15 |
| Age | 77.18 ± 8.58 | 79.06 ± 7.58 | 0.13 |
| tHcy (μmol/L)† | 13.64 ± 4.59 | 15.12 ± 4.42 | — |
| CRP (mg/L)† | 4.32 ± 8.49 | 3.46 ± 8.60 | — |
| tHcy (μmol/L)‡ | 12.94 (12.16, 13.77)* | 14.49 (13.46, 15.56)* | 0.02 |
| CRP (mg/L)‡ | 1.47 (1.11, 1.96)* | 1.21 (0.90, 1.63)* | 0.37 |
Mean ± standard deviation.
†Raw scores.
‡Log transformed scores.
*Geometric mean (95% confidence interval).